7. Polisomnografie Durations Patient name : SERESAN Acq : 707 First name : MARIA Type : Adult Sex : F Started : 11/4/2008 at 10:18:13 PM Birth date : 9/20/1988 Stopped : 11/5/2008 at 7:01:13 AM Patient age : 20 years Duration : 8:43:00 (523.0 min) Recording duration : 523.0 min Recording start -> end TIB : 523.0 min Light off -> Light on SPT : 488.5 min Sleep Onset -> Last Sleep Page TST : 469.0 min REM + NREM + MVT (during SPT) WK before sleep : 32.0 min WK from Light off to Sleep onset WK during sleep : 19.5 min SPT - TST WK after sleep : 0.0 min WK from Last sleep page to Light on TWK duration (tot) : 51.5 min All WK summed REM duration : 55.0 min REM (during TIB) NREM duration : 416.0 min S1 + S2 + S3 + S4 (during TIB) SWS duration : 78.5 min S3 + S4 (during TIB) Movement : 0.5 min MVT (during TIB)
8. Caracteristicile somnului Latencies From Light off (min) From Sleep onset (min) Sleep onset 34.5 - S1 32.0 12.5 S2 34.5 0.0 S3 144.5 110.0 S4 REM 253.5 219.0 Sleep efficiency 1 : 89.7% 100 x TST/TIB Sleep efficiency 2 : 96.0% 100 x TST/SPT Sleep efficiency 3 : 28.5% 100 x (N3+REM)/TST Inter-sleep WK : 4.0% WK in sleep / SPT
9. Evenimente respiratorii CA OA MA Sum Ap HYP Events Settings (sec) 10.0 10.0 10.0 - 10.0 - Number 4 47 1 52 376 428 Max (sec) 15.5 22.5 12.0 22.5 53.0 53.0 Mean (sec) 13.4 12.0 12.0 12.1 16.0 15.5 Tot duration (min) 0.9 9.4 0.2 10.5 100.0 110.5 TST (469.0 min) % of TST 0.2 2.0 0.0 2.2 21.3 23.6 Index [#/h TST] 0.5 6.0 0.1 6.7 48.1 54.8
12. REM #/h (REM) NREM #/h(NREM) TST #/h (sleep) RDI 31.6 57.8 54.8 Central apnea total duration : 1.68 minutes (0.3% of sleep) Total number of central apnea : 12 ( 1.5 CA/h (sleep)) Sigh rate : 8% Periodic breathing total duration : 1.57 minutes (0.3% of sleep)
15. Saturatia in O2 WK REM NREM TOTAL Fail duration (min) 0.2 0.0 0.0 0.2 Average (%) 98 97 96 96 Desat Index (#/hour) 8.7 29.7 27.2 Duration desat/hour 1.8 6.3 5.8 Desat max (%) 0 5 19 19 Desat max dur (sec) 0.0 20.0 45.0 45.0
16. Desaturari Longest continuous duration spent below 0%: 0.0 minute(s) Lowest SpO 2 (>= 2 seconds) [%]: 79 # Episodes (>= 5.0 minutes) SpO 2 < 88 %: 0 Longest duration SpO 2 < 88 % 0.0 minute(s) Mean of the resp. event SpO 2 min levels [%] : 93 Mean of the resp. event SpO 2 min levels with desat [%] : 92 Minimum of the resp. event SpO 2 min levels [%] 79
17. Total number of WK or MVT episodes : 3 Arousal index : 5.8/h(sleep) % of pages with arousal during sleep : 4.8 Number of arousals associated with leg movements : 0 Number of arousals NOT associated with leg movements : 45
25. CPAP 80% din pacienţi acceptă CPAP ca terapie de lungă durată la domiciliu W. T. McNicholas, M. R. Bonsignore, Eur Respir J , January 2007; 29:156-178
26.
27. CPAP: impact ul asupra activităţii din timpul zilei Engleman HM et al, Lancet 1994;343:572–575 Engleman HM et al, Thorax 1998;53:341–345 Redline S et al, AJRCCM 1998;57:858–865 Jenkinson C et al, Lancet 1999;353:2100–2105 Ballester E et al, AJRCCM 1999;159:495–501 Montserrat et al, AJRCCM, 2001, 164:608-13 nCPAP aduce îmbunătăţiri semnificative pe somnolenţă şi calitatea vieţii la pacienţii cu simptome de SAS moderată sau severă R Davies and J Stradling, AJRCCM, 2000, 161:1775-8
31. Mortalit atea crescută la pacienţii care nu primesc CPAP Doherty LS Chest. 2005;127:2076-2084 Long-term Effects of Nasal Continuous Positive Airway Pressure Therapy on Cardiovascular Outcomes in Sleep Apnea Syndrome* Chest. 2005;128:624-633. Mortality in Obstructive Sleep Apnea-Hypopnea Patients Treated With Positive Airway Pressure* Francisco Campos-Rodriguez, Marti, S, Sampol, G, Muñoz, X, et al Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002;20 ,1511-1518
32.
33.
34.
35. Circumferinţa abdominală medie 120,06 cm Obezitatea abdominală (plus ≥2 elemente) - element obligatoriu în noua definiţie a sindromului metabolic: peste 80 cm la femei şi peste 94 la bărbaţi la europeni Lancet 2007; 369:2059-2061